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To analyze cellular reprogramming at the single-cell
level, mass cytometry was used to simultaneously
measure markers of pluripotency, differentiation,
cell-cycle status, and cellular signaling throughout
the reprogramming process. Time-resolved progres-
sion analysis of the resulting data sets was used to
construct a continuous molecular roadmap for three
independent reprogramming systems. Although
these systems varied substantially in Oct4, Sox2,
Klf4, and c-Myc stoichiometry, they presented a
common set of reprogramming landmarks. Early in
the reprogramming process, Oct4highKlf4high cells
transitioned to a CD73highCD104highCD54low partially
reprogrammed state. Ki67low cells from this interme-
diate population reverted to a MEF-like phenotype,
but Ki67high cells advanced through the M-E-T
and then bifurcated into two distinct populations:
an ESC-like NanoghighSox2highCD54high population
and a mesendoderm-like NanoglowSox2lowLin28high
CD24highPDGFR-ahigh population. The methods de-
veloped here for time-resolved, single-cell progres-
sion analysis may be used for the study of additional
complex and dynamic systems, such as cancer pro-
gression and embryonic development.
INTRODUCTION
Reprogramming somatic cells to a pluripotent state by forced
expression of transcription factors is a dynamic process. How
a somatic cell successfully undergoes this transition is poorly un-
derstood because low efficiencies, long latency times, and asyn-
chronous progression impede molecular analysis (Hanna et al.,
2009; Wernig et al., 2008). Characterization of bulk populations
over time has given insight into how entire reprogramming pop-
ulations progress (Li et al., 2010; Mikkelsen et al., 2008; Sama-
varchi-Tehrani et al., 2010; Soufi et al., 2012), but as most cells
undergoing this process fail to reprogram, bulk analyses ofCsuch processes are necessarily biased toward measurement of
unproductive reprogramming events.
To address these concerns, several groups have sought to
identify and characterize productive reprogramming popula-
tions. An early role for transgene stoichiometry was deduced
from transgene integrations in induced pluripotent stem cells
(iPSCs) and by sorting fibroblasts according to transgene
expression levels (Papapetrou et al., 2009; Wernig et al., 2008).
Sox2low, Oct4high, Klf4high was found to be an optimal combi-
nation and was further verified with polycistronic constructs
expressing different transgene stoichiometries (Carey et al.,
2009). Single-cell time-lapse imaging analysis revealed an early
proliferation phenotype (Koche et al., 2011; Smith et al., 2010).
Early work suggested the progression of reprogramming states
with sequential acquisition of the pluripotency markers alkaline
phosphatase, SSEA1, Nanog, and Oct4 (Stadtfeld et al., 2008).
Additionally, repression of the fibroblast marker Thy1 and loss
of retroviral expression was observed to occur early in the pro-
cess. Characterization of these states suggested two waves of
reprogramming occur with the first being mediated by c-Myc
and Klf4 and the second by Oct4, Sox2, and Klf4 (Polo et al.,
2012).
Stable partially reprogrammed lines have also been isolated
and characterized (Chen et al., 2013; Ichida et al., 2009; Meiss-
ner et al., 2007; Mikkelsen et al., 2008; Polo et al., 2012; Srid-
haran et al., 2009; Theunissen et al., 2011; Wernig et al., 2008).
These partially reprogrammed cells arise late in the process
but prior to the acquisition of pluripotency and can be derived
from multiple reprogramming populations including fibroblasts,
neural stem cells, and B cells (Mikkelsen et al., 2008; Theunissen
et al., 2011; Wernig et al., 2008). Morphologically they resemble
iPSCs, but have not acquired pluripotency as shown by their
inability to form teratomas and dependence on the reprogram-
ming transgenes (Wernig et al., 2008). Although the majority of
these cells do not acquire pluripotency under standard condi-
tions, they can be pushed to a pluripotent state with chemical
treatment of 5-aza-cytidine and vitamin C or by overexpression
of Nanog, suggesting that they resemble an intermediate state
where roadblocks inhibit pluripotency acquisition (Mikkelsen
et al., 2008; Theunissen et al., 2011).
Although characterization of enriched intermediates has been
useful, analysis is still highly reliant on bulk populations whereell Stem Cell 16, 323–337, March 5, 2015 ª2015 Elsevier Inc. 323
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heterogeneity is still prevalent. Recently, Buganim et al. (2012) at-
tempted to address this by conducting single-cell mRNAanalysis
to identify an early stochastic phase of reprogramming followed
by a late deterministic phase correlated with Sox2 expression.
Despite the importance of the findings in this study, its conclu-
sions may have been limited by the relatively small sample size
of 96 cells that were assayed at each time point, coupled with
low reprogramming efficiencies where only two in 100 cells
may successfully reprogram. To this end, we have characterized
the reprogramming process by single-cell mass cytometry, a
flow cytometry technique that uses rare earth metal isotopes
for antibody labeling and detection (Bandura et al., 2009). Mass
cytometry produces results that are essentially identical to con-
ventional fluorescent flow cytometry (Bendall et al., 2011), but
allows over 40 different parameters to be measured simulta-
neously at 500 cells per second. Using mass cytometry, we
have analyzed three different reprogramming lines during the first
3–4 weeks of reprogramming. Time-resolved, high-dimensional
progression analysis of the mass cytometry data sets facilitated
construction of continuous molecular maps of reprogramming,
which should serve as valuable resources for the continued
development of improved iPSC reprogramming protocols.
RESULTS
Single-Cell Analysis of Cellular Reprogramming
by Mass Cytometry
Three cellular reprogramming systems were used for this study:
(1) Oct4-GFP primary mouse embryonic fibroblasts (MEFs) that
express GFP from the endogenous Oct4 locus (Lengner et al.,
2007), (2) Nanog-Neo secondary MEFs that express the
neomycin resistance gene from the endogenous Nanog locus
(Wernig et al., 2008), and (3) Nanog-GFP secondary MEFs that
expresses GFP from the endogenous Nanog locus (Wernig
et al., 2008). To obtain a comprehensive view of cellular reprog-
ramming in the three MEF systems, cell samples were collected
on every other day of the reprogramming time course. The re-
programming regimen consisted of Dox induction for 16 days
followed by Dox withdrawal and the addition of LIF (Figure 1A).
Additional samples were collected on days 1 and 17, as these
days represent points of significant transition in the reprogram-
ming process, immediately after Dox induction and Dox with-
drawal, respectively. Samples were collected over 20 days for
the primary Oct4-GFP MEFs, and the time course was extended
to 30 days for the secondary Nanog-Neo and Nanog-GFP MEFs
because the reprogramming process was found to be slower in
these systems.
At each collection time point, cell cultures were dissociated
into a single-cell suspension, permeabilized (Krutzik et al.,Figure 1. Time Course Analysis of iPSC Reprogramming by Mass Cyto
(A) Tissue culture conditions for time course analysis of iPSC reprogramming. G
(B) Schematic of sample collection and processing for mass cytometric analysis
(C) Cell multiplexing and deconvolution with a 6-metal MCB scheme.
(D) All pairwise biaxial plots for antibody-measured parameters from a single de
lighted in red are shown over the full reprogramming time course in (E)–(H).
(E–H) Biaxial plots covering the full reprogramming time course for the following
p53 3 phospho-S6.
See also Figure S1 and Table S1.
C2005), and then multiplexed by Mass-tag Cell Barcoding (Bod-
enmiller et al., 2012) before antibody staining (Table S1) and
mass cytometry analysis (Bendall et al., 2011) (Figure 1B). A
six-metal barcoding scheme was used to encode 20 unique
Mass-tag barcodes (Figure 1C) (Zunder et al., 2015), allowing
the entire time course for each MEF system to be pooled and
stained within a single tube, eliminating tube-to-tube variability
in antibody staining and minimizing the effect of variable instru-
ment sensitivity. After mass cytometry measurement of the mul-
tiplexed samples, barcode deconvolution was performed to
recover individual samples from the pooled data set (Figure 1D).
Over the course of reprogramming, the MEF marker Thy1
decreased and the pluripotency marker SSEA1 increased (Fig-
ure 1E), in agreement with previous studies (Stadtfeld et al.,
2008). Elevated Nanog expression was not observed until after
release from Dox-induced transgene expression on day 16
and correlated with expression of ICAM-1/CD54 (Figure 1F), a
marker associated with successful cellular reprogramming
(O’Malley et al., 2013). PDGFR-a was expressed by MEFs,
depressed during the initial stages of reprogramming, and grad-
ually returned during the later stages of reprogramming. One
late-stage cell population expressed PDGFR-a at a higher level
than seen in the uninducedMEFs, and another Lin28-expressing
population expressed PDGFR-a at an intermediate level (Fig-
ure 1G). Total protein levels of the tumor suppressor protein
p53, which has been shown to inhibit cellular reprogramming
(Hong et al., 2009; Kawamura et al., 2009; Li et al., 2009; Mario´n
et al., 2009; Utikal et al., 2009), increased rapidly after transgene
induction, and phosphorylation levels of the ribosomal protein
S6, a downstream marker of mTOR activity and translational
control (Dufner andThomas, 1999) decreased rapidly (Figure 1H),
indicating a stress-related response to forced expression of the
four transcription factors (Feng et al., 2005).
Hierarchical clustering identified MEF-like markers that
decreased over time, transitional markers that appeared at inter-
mediate time points, and ESC-like markers that appeared during
the latest stages of reprogramming (Figures S1A–S1D). Repli-
cate analysis (Figure S1E) indicated these observed trends are
reproducible. While hierarchical clustering provides a useful
overview of the data sets, this approach does not take advan-
tage of the single-cell nature of the data and is not well suited
for analysis of low abundance populations. Therefore, additional
methods were employed to better exploit the single-cell nature
of the three reprogramming time course data sets.
High-Dimensional Analysis of Cellular Reprogramming
by Force-Directed Layout of Clustered Cells
Spanning-tree progression analysis of density-normalized
events (SPADE) has proven useful in identifying relationshipsmetry
reen arrows indicate sample collection time points.
.
convoluted cell sample: Oct4-GFP primary MEF infection, day 16. Plots high-
markers: (E) Thy1 3 SSEA1, (F) CD54 3 Nanog, (G) PDGFRa 3 Lin28, and (H)
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Figure 2. Force-Directed Layout of MEF Reprogramming SPADE Clusters
(A–G) Schematic of the SPADE algorithm and modified FLOW-MAP layout. A 2D synthetic example data set (A) is first downsampled to a uniform density in n-
dimensional space (B), clustered hierarchically, and then upsampled (C), after which the cell clusters are connected by a minimum spanning tree, shown with the
true 2D coordinates (D) and minimum spanning tree-derived layout (E), or alternatively connected by a FLOW-MAP graph, shown with the true 2D coordinates (F)
(legend continued on next page)
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between cell types in high-dimensional space, by downsampling
to uniform density (Figures 2A and 2B), hierarchical clustering
(Figure 2C), and connecting the resulting clusters with a mini-
mum spanning tree (MST) (Figure 2D) that can be visualized in
two dimensions (Figure 2E) to reveal high-dimensional relation-
ships between cell types (Bendall et al., 2011; Linderman et al.,
2012; Qiu et al., 2011). The MST used by SPADE is susceptible
to overfitting the data and is not robust to local variation (Figures
2D and 2E). To improve the ability of the SPADE algorithm to
robustly identify high-dimensional relationships between cell
types, the MST was replaced with a more highly connected
graph structure, where the number of connections between
cell clusters is determined by local density (Figure 2F). This
new graph structure is then employed to produce a force-
directed layout of a weighted graph containing multidimensional
agglomeratively clustered points (FLOW-MAP) plot. The FLOW-
MAP layout of cell clusters is more reproducible than a MST-
derived layout, because the underlying graph structure is highly
connected and therefore less susceptible to local edge and clus-
ter variability (Figure 2G).
To facilitate comparison between the three reprogramming
systems, each timed sample was clustered individually and
then combined into a single FLOW-MAP graph (Figure 2H).
Cell clusters from two mESC samples and a partially reprog-
rammed iPSC line were also included as reference points. As
expected, the three MEF systems occupied a similar high-
dimensional space before Dox induction, characterized by high
expression of MEF markers such as Thy1 (Figure 2I), PDGFRa,
and MEFSK4 (Figure S2). Late in the reprogramming process,
all three culture systems contained ESC-like cell populations
that expressed high levels of non-transgene markers of pluripo-
tency such as SSEA1, Lin28, and Nanog (Figures 2J–2L). These
ESC-like populations formed distinct groups in the combined
FLOW-MAP layout that may represent metastable pluripotent
states (Hayashi et al., 2008) or may be unique stages on the
path to a pluripotent ‘‘ground state’’ (Ying et al., 2008). These
populations vary mainly between high-level and mid-level ex-
pression of pluripotency markers and group closely in the graph
with the mESC control samples.
Time-Resolved Progression Analysis of iPSC
Reprogramming
SPADE and the FLOW-MAP algorithm draw connections be-
tween populations that are similar in n-dimensional space, but
cannot utilize the temporal information present in time course
data sets. To exploit this temporal information, the FLOW-MAP
algorithmwas extended to includemultiple graph drawing steps,
where cell clusters are added to the graph sequentially for each
time point (Figures 3A, 3B, and S3A–S3C). In this scheme, only
cell clusters that reside in identical or adjacent time points mayand FLOW-MAP-derived layout (G). Two clusters that are close in 2D space, far a
another with the FLOW-MAP layout are indicated by purple arrows.
(H) Combined FLOW-MAP analysis of the full time course data sets for the Oc
clustering was performed on each sample/time point individually using the followi
Lin28, MEFSK4, Nanog, Oct4, SSEA1, Sox2, Thy1, and c-Myc to produce 500 clus
single FLOW-MAP graph layout and colored by cell system and time point as ind
(I–L) The FLOW-MAP layout from Figure 4H, colored to indicate the protein expres
See also Figure S2.
Cbe connected in the final FLOW-MAP graph. Display of the re-
sulting x-y layouts with time on the z axis in a 3D environment
such as PyMOL (http://www.pymol.org) (Figure 3C) allows simul-
taneous visualization of experimental time point along with addi-
tional markers (Supplemental Files 1, 2, and 3). Time-resolved
FLOW-MAP analysis revealed several similarities between the
Oct4-GFP, Nanog-Neo, and Nanog-GFP MEF reprogramming
systems (Figures 3D–3F), as well as two additional reprogram-
ming time course experiments (Figures S3D and S3E).
After Dox induction, all three systems contain populations with
mixed stoichiometry of the four reprogramming factors, and the
Oct4-GFP and Nanog-Neo MEFs contained a sizable proportion
of cells that do not express any of the four reprogramming fac-
tors at the protein level. The reprogramming factor non-express-
ing FLOW-MAP branches show increased PDGFR-a and CD54/
ICAM-1 expression at later time points, behavior also observed
in uninfected mock-reprogramming MEF cultures (Figure S3F).
An Oct4highKlf4high population emerged from the mixed stoichi-
ometry population in the FLOW-MAP plot of each of the three re-
programming systems. This population immediately precedes a
partially reprogrammed state in the FLOW-MAP plot, which in
turn extends to the mesenchymal-epithelial transition (MET).
Ki67low cells appeared to revert to a MEF-like state, while pro-
liferative Ki67high cells appeared to transition into a Nanoghigh
population. At the end of the reprogramming time course, the
Nanoghigh population diverged into twomajor end-stage popula-
tions in the FLOW-MAP plot: one that was ESC-like with high
levels of Oct4, Sox2, and Nanog protein expression, and another
state that was Lin28high but low in Sox2 and Nanog protein
expression, which represents a state immunophenotypically
similar to multipotent mesendodermal progenitor cells (Tada
et al., 2005; Wang et al., 2012).
Variability in Reprogramming Factor Stoichiometry
Exogenous reprogramming factor expression is the sole driver of
cellular reprogramming (Takahashi and Yamanaka, 2006), and
the stoichiometry and timing of their expression plays a critical
role in the successful transition to a pluripotent state (Carey
et al., 2011; Papapetrou et al., 2009). We therefore investigated
the differences in transgene stoichiometry between the three re-
programming MEF systems and their functional consequences
at the single cell level. The percentage of cells that were positive
for Oct4, Sox2, Klf4, and c-Myc during Dox induction provided a
global overview of transgene expression at the protein level in
the threeMEF reprogramming systems (Figure 4A). While the an-
tibodies used for mass cytometry do not distinguish between
endogenous and exogenous reprogramming factors, these
measurements are likely to be primarily exogenous because
the Dox-induced expression levels are substantially higher
than endogenous levels, even in the pluripotent state (Figurespart on the minimum spanning tree layout and correctly placed adjacent to one
t4-GFP, Nanog-GFP, and Nanog-Neo reprogramming systems. Hierarchical
ng markers: PDGFRa, CD24, CD44, CD54, CD73, EpCAM, H3K9ac, Ki67, Klf4,
ters per sample. The cell clusters from each sample were then combined into a
icated.
sion level of the specified markers: (I) Thy1, (J) SSEA1, (K) Lin28, and (L) Nanog.
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Figure 3. Time-Resolved Progression Analysis of iPSC Reprogramming
(A–C) Schematic of the FLOW-MAP algorithmmodified for time-ordered data sets. A 2D synthetic example data set (A) is downsampled and clustered individually
as in Figures 2A–2C and then clusters from each time point are added to the FLOW-MAP graph sequentially (B), shown here in the final force-directed layout
position. 3D representation with the FLOW-MAP layout on the x-y axes and sequential time points on the z axis allows improved visualization of the relationship
between marker intensity (synthetic marker 2 is shown) and time (C).
(D–F) Time-resolved FLOW-MAP analysis of the three MEF reprogramming systems: Oct4-GFP primary MEFs (D), Nanog-GFP secondary MEFs (E), and Nanog-
Neo secondary MEFs (F). Hierarchical clustering (200 clusters per sample) and FLOW-MAP graph construction were performed using 18 marker expression
levels: Oct4, Sox2, Klf4, c-Myc, Nanog, GFP, Lin28, SSEA1, EpCAM, CD54, CD73, Thy1, MEFSK4, PDGFR-a, CD24, CD44, H3K9ac, and Ki67. GFP indicates
endogenous Oct4 promoter activity in the Oct4-GFP MEFs, endogenous Nanog promoter activity in the Nanog-GFP MEFs and was not used for clustering the
Nanog-Neo MEFs. The resulting FLOW-MAP graphs are colored by time point, and cell populations common among the three reprogramming systems are
labeled with colored dashed lines.
See also Figure S3 and Files S1, S2, and S3.S4A and S4B), and expression levels fell rapidly after Dox with-
drawal on day 16 (Figures 4A, S4A, and S4B).
Most of the 16 possible binary transgene combinations were
well represented in the Oct4-GFP primary MEFs on day 2, but
the Nanog-Neo secondary MEFs display high Oct4 protein328 Cell Stem Cell 16, 323–337, March 5, 2015 ª2015 Elsevier Inc.expression and low Sox2 protein expression, while the reverse
is true for the Nanog-GFP secondary MEFs (Figures 4A, S4A,
and S4B), corroborating previous mRNAmeasurements (Wernig
et al., 2008). Early time point replicate analysis indicated that
the opposite Oct4/Sox2 stoichiometries of the Nanog-Neo
AB
C D
Figure 4. Variability in Transgene Stoichiometry between Reprogramming Systems and within Each System
(A) Percentage of cells with positive expression for each of the four transgenes over course of reprogramming. Percentages are based on the gates shown in
Figures S4A and S4B.
(B) Percentage of cells that fall within each of 16 possible binary combinations of transgene expression over the course of reprogramming. Percentages are based
on the gates from Figures S4A and S4B. Each binary combination is indicated by the key on the right, where black boxes denote positive expression above
background.
(C) Cell-cycle gating strategy for assignment to G0, G1, S, G2, or M phase using IdU incorporation and the markers Ki67, phospho-Histone H3, and Cyclin B1.
(D) Percentage of cells in each cell-cycle phase for selected c-Mychigh and c-Myclow populations of the time course of Dox induction.
See also Figure S4.and Nanog-GFP secondary MEFs were reproducible (Fig-
ure S4C). The observed temporal shift of transgene stoichiome-
tries is likely due to increased proliferation of cells that express
certain transgene combinations or due to selective lentiviral
silencing. To assess selective proliferation rates, the level of
IdU incorporation and the protein expression levels of Ki67,
phospho-Histone H3, and Cyclin B1 in the reprogramming sam-
ples were used to quantify the percentage of cells in G0, G1, S,
G2, and M phase of the cell cycle (Figure 4C) (Behbehani et al.,
2012).CExpression of the reprogramming factor c-Myc was strongly
correlated with cell-cycle progression across all combinations
of the remaining three transgenes (Figure 4D). c-Myc has been
reported to act as a global amplifier of transcription (Lin et al.,
2012) and may play that role during cellular reprogramming as
well. We observed a linear relationship between c-Myc protein
expression and the reprogramming factors Oct4 and Klf4, but
not with Sox2 (Figures S4D and S4E). c-Myc protein expression
levels also correlated with markers of proliferation andmetabolic
activity (Figure S4F), consistent with its role as a driver of cellell Stem Cell 16, 323–337, March 5, 2015 ª2015 Elsevier Inc. 329
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Figure 5. A Pre-MET Reprogramming State Marked by Oct4 and Klf4 Expression
(A) Time-resolved FLOW-MAP plots of similarity to partially reprogrammed iPSCs for the three MEF reprogramming systems. Similarity was calculated by the
manhattan distance metric relative to the median expression levels of Oct4, Sox2, Klf4, c-Myc, Nanog, Lin28, SSEA1, EpCAM, CD54, CD73, Thy1, MEFSK4,
PDGFR-a, CD24, CD44, H3K9ac, and Ki67 in the partially reprogrammed cell line SC4. Oct4/Klf4 expressing cell clusters that precede the highly SC4-like
population are indicated by magenta dashed lines, and the progression of time is indicated by black arrows.
(B) Time-resolved FLOW-MAP plots for the three reprogramming systems (Figures 3D–3F) colored by Oct4 and Klf4 protein expression.
(C) 2D cluster analysis of day 16 subpopulations in combination with differentiated, pluripotent, and partially reprogrammed samples. Day 16 samples for the
three reprogramming systemswere hierarchically clustered into five populations each and then cluster analysis was performed on these populations to determine
their similarity to day 0 MEFs, ESCs, and the partially reprogrammed iPSC line SC4. Heatmap plots of the markers used for clustering are shown, along with
dendrograms for the 2D cluster analysis performed on each reprogramming system.
(D) Oct43Klf4 biaxial plots of the Oct4-GFP primaryMEF reprogramming time course, gated to show the CD104highCD54low and CD104lowCD54high populations.
(E) Time-resolved FLOW-MAPplots (Figures 3D–3F) colored by EpCAMprotein expression level. The SC4-like population is indicated by amagenta dashed line in
each plot, and the progression of time is indicated by black arrows.
(F) Intracellular sort gating strategy for mRNA extraction from the day 8 Nanog-Neo Secondary MEF sample. The Oct4lowKlf4low gate (OK) is colored blue, the
Oct4highKlf4low gate (O+K) is colored purple, the Oct4highKlf4lhighEpCAMlow gate (O+K+E) is colored green, and the Oct4highKlf4highEpCAMhigh gate (O+K+E+)
is colored red.
(G) Hierarchical clustering of mRNA microarray data from the four intracellular-sorted populations, which are labeled and colored as in (F).
(H) SelectedmRNA expression level measurements for the four intracellular-sorted Nanog-Neo SecondaryMEF day 8 populations, which are labeled and colored
as in (F).
(legend continued on next page)
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proliferation. However, this correlation was lost for a set of cell-
signaling proteins in the Oct4-GFP primary MEFs, possibly
because these cells were virally transduced unlike the secondary
MEFs. The innate immune response to retroviral infection has
been reported to improve the efficiency of cellular reprogram-
ming by inducing TLR signaling though NF-kB (Lee et al.,
2012). Consistent with this model, we observed the Oct4-GFP
MEFs reprogrammed faster than the Nanog-Neo and Nanog-
GFP secondary MEFs, and protein levels of the NF-kB inhibitor
IkBawere anti-correlated with c-Myc in these cells (Figure S4G).
An Oct4/Klf4-Expressing Partially Reprogrammed
State Precedes the MET
Comparison to the partially reprogrammed iPSC line SC4 (Meiss-
ner et al., 2007) revealed that an immunophenotypically similar
population of cells was present between days 8 and 16 in all
three reprogramming MEF systems (Figure 5A). This SC4-like
population is Oct4highKlf4high in all three reprogramming systems
and is preceded by an earlier immunophenotypically distinct
Oct4highKlf4high transitional population (Figure 5B). 2D cluster
analysis of the day 16 samples in combination with MEF, ESC,
and SC4 reference samples identified CD73 and CD54/ICAM-1
as the markers that best distinguish this partially reprogrammed
population, which is CD73high and CD54/ICAM-1low (Figure 5C).
The marker CD73 has previously been used to identify a rare
somatic cell type with extensive lineage plasticity that can differ-
entiate to all three germ layers (Roy et al., 2013). Additional ex-
periments identified CD104 as another positive marker for this
SC4-like population. Gating by CD104 and CD54/ICAM-1 segre-
gated the reprogramming culture into Klf4high and Klf4low popula-
tions as early as 2 days after Dox induction, and at later time
points this gating scheme separated Oct4highKlf4high from
Oct4lowKlf4low populations (Figure 5D). This SC4-like population
precedes the MET, as measured by expression of EpCAM (Fig-
ure 5E), an E-cadherin-associated epithelial surface marker (Sa-
mavarchi-Tehrani et al., 2010) and therefore represents an earlier
stage of the reprogramming process.
To further characterize this Oct4highKlf4highEpCAMlow transi-
tional SC4-like population, a sample of methanol-permeabilized
day 8 Nanog-Neo MEFs was FACS-sorted by Oct4, Klf4, and
EpCAM protein expression (Figures 5F and S5A) and then
mRNA was extracted from these sorted populations for microar-
ray analysis (Figures 5G, S5B, and S5C). Oct4, Klf4, and EpCAM
mRNA expression levels follow protein expression levels as
measured by the FACS antibodies (Figure 5H), although an in-
crease in mRNA expression of the epithelial marker EpCAM
precedes protein expression in the EpCAMlow SC4-like popula-
tion. Other epithelial markers such as E-cadherin and Crb3
show elevated mRNA expression to varying degrees in this
Oct4highKlf4highEpCAMlow transitional population, but mesen-
chymal markers such as Vimentin and Slug remain elevated
as well.
During late reprogramming, high levels of CD73 become asso-
ciated with low Ki67 expression (Figure 5I) indicating that a sub-(I) Ki67 3 CD73 biaxial plots for day 16 reprogramming samples. CD73highKi67lo
(J) Time-resolved FLOW-MAP plots for Oct4-GFP primary MEFs, colored by CD73
by a magenta dashed line in each plot.
See also Figure S5.
Cset of the CD73high population begins to exit the cell cycle. In the
Oct4-GFP primary system, a well-defined trajectory from the
CD73highKi67low population toward MEF reversion is present in
the FLOW-MAP layout (Figure 5J). This CD73highKi67low popula-
tion is almost completely absent from theNanog-GFP secondary
reprogramming MEFs (Figure 5I), and there is very little MEF
reversion in this system as well (Figure 3F). This suggests that
CD73highKi67low represents an unstable population distinct
from the SC4-like state that is prone to revert to a fibroblast-
like population.
Cellular Reprogramming End States Are Controlled
by Cell Signaling
After Dox release on day 16, reprogramming MEFs progress
to one of three primary cell populations: (1) MEFSK4high, (2)
Lin28high, or (3) Nanoghigh (Figure 6A). The MEFSK4high popu-
lation appears to be a reversion to a MEF-like state and is
preceded by a CD73highKi67low population and correlated with
EpCAMlow MET failure (Figure 6B). The MEF-like MEFSK4high
population also arises from OSKM non-expressing cells in two
of the three reprogramming system FLOW-MAP plots, which
gradually change over the time course with decreased Thy1
and increased PDGFR-a and CD54 expression. The shift in pro-
teomic signature of these MEF-like cells is likely due to changes
in their local environment, because the MEFs are plated very
sparsely, but become highly confluent by the end of the reprog-
ramming time course.
EpCAM-expressing cells proceed to either the Nanoghigh or
Lin28high end stage populations in the FLOW-MAP plots of all
three reprogramming MEF systems. Immunofluorescence imag-
ing identified separate colonies each containing one of these
three populations (Figures 6C–6E), indicating that they arise
in parallel as suggested by the FLOW-MAP trajectories. The
Nanoghigh population is ESC-like with elevated expression of
the pluripotency markers Oct4, Sox2, SSEA1, Klf4, and acetyl-
Histone H3 (Lys9), as well as mid-level CD54 expression.
The Lin28high population forms a separate diverging branch in
the three reprogramming systems and is marked by elevated
CD24 and PDGFR-a expression, as well as lower levels of the
pluripotency markers Oct4, Sox2, SSEA1, Klf4, and acetyl-His-
toneH3 (Lys9) (Figure 6F). TheOct4-drivenGFP reporter persists
in this population longer than Oct4 protein itself, which could be
due to GFP having a longer half-life than Oct4 in this cell type.
The Nanoghigh and Lin28high populations both diverge from a
common branch of the FLOW-MAP plot, suggesting an unstable
intermediate state that resolves into an ESC-like Nanoghigh state
of pluripotency or a mesendoderm-like Lin28high state (Tada
et al., 2005; Wang et al., 2012). In the Oct4-GFP primary
MEFs, this common branch point is characterized by elevated
levels of phospho-S6 (Ser235/236) and decreased levels of
IkBa (Figure 6G). As cells progress from the branch point
to the Lin28high and Nanoghigh populations, phospho-Stat3
(Tyr705) increases in both populations, while total b-catenin is
higher in the mesendoderm-like Lin28high population andw population is indicated by a magenta dashed line.
and Ki67 protein expression level. The CD73highKi67low population is indicated
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Figure 6. End-Stage Trajectories of Cellular
Reprogramming: MEF-like, ESC-like, and
Lin28high
(A) Time-resolved FLOW-MAP plots for Oct4-GFP
primary MEFs, colored by protein expression level
of the indicated markers. The end-stage trajec-
tories are indicated by black arrows.
(B) Overview FLOW-MAP plot of the late stage
reprogramming Oct4-GFP primary MEFs. Day 16
Dox release and the MET are indicated by dashed
lines.
(C–E) Immunofluorescence microscopy of
day 24 primary reprogramming MEFs stained with
anti-Lin28 antibody (Alexafluor-488 secondary
antibody), anti-Nanog antibody (Alexafluor-594
secondary antibody), and Hoechst dye. Repre-
sentative images of a Lin28highNanoghigh colony
with mESC-like morphology (C), a Lin28high
Nanoglow colony with epithelial cobblestone mor-
phology (D), and a Lin28highNanoglow colony with
fibroblast-like morphology adjacent to a Lin28high
Nanoghigh colony with mESC-like morphology (E).
(F and G) Lin28high and Nanoghigh branches of the
Oct4-GFPprimaryMEF time-resolvedFLOW-MAP,
colored by markers of pluripotency (F) and cell
signaling (G). Thescale bar in each image is 250mm.
See also Figure S6.phospho-Erk and phospho-Src are higher in the ESC-like
Nanoghigh population. Cell signaling is highly sensitive to
changes in culture conditions such as cell density, colony size,
and the relative depletion of the culture medium, especially for
upstream and membrane proximal signaling proteins such as
phospho-Erk, which was not elevated in the ESC-like Nanoghigh
populations of the secondary reprogramming MEFs (Figures S6
and S7). The concerted changes observed in cell signaling in all
three reprogramming systems, while somewhat variable be-
tween systems, still suggest a critical role for cell signaling in
the final determination phase of iPSC reprogramming.
To investigate the functional relevance of the implied signaling
pathways in the end stage reprogramming populations, Oct4-
GFP primary reprogramming MEFs were treated with a panel
of small molecule kinase inhibitors from the point of Dox removal
on day 16 until sample collection on day 20 (Figure 7A). IKK In-
hibitor X, an IkB kinase inhibitor, and BEZ-235, a dual PI3K/
mTOR inhibitor, were chosen due to the changes observed in to-
tal IkB and phospho-S6 observed during progression through332 Cell Stem Cell 16, 323–337, March 5, 2015 ª2015 Elsevier Inc.the FLOW-MAP branch leading to
Lin28high and Nanoghigh cell populations.
CHIR-99021, a GSK3 inhibitor, and PD-
0325901, a MEK inhibitor, were chosen
due to their known role in pluripotency
maintenance and cellular reprogramming,
in particular when used in combination as
the ‘‘2i’’ condition (Silva et al., 2008; Ying
et al., 2008).
Biaxial gating of the fourmutually exclu-
sive Nanoghigh, Lin28high (Nanoglow),
CD54high, andMEFSK4high (CD54low) pop-
ulations (Figure 7B) allowed quantification
of the changes in population distributionbetween the inhibitor-treated Oct4-GFP primary MEF day 20
endpoint samples (Figure 7C). The most dramatic change in
end-stage population distribution occurred after treatment with
the PI3K/mTOR inhibitor, which resulted in almost complete
loss of the Lin28high and Nanoghigh populations. This result dem-
onstrates an essential role for the PI3K/Akt/mTOR pathway in
late stage cellular reprogramming or pluripotency maintenance
and indicates an important functional role for the burst of S6
phosphorylation observed in the EpCAMhigh branch of the
Oct4-GFP primary MEF FLOW-MAP plot (Figure 6G). Previous
studies have found roles for PI3K and mTOR signaling in plurip-
otency maintenance (Murakami et al., 2004; Paling et al., 2004),
but the role of PI3K/Akt/mTOR signaling during cellular reprog-
ramming is less clear, with some studies reporting increased re-
programming efficiency uponmTOR inhibition (Chen et al., 2011;
He et al., 2012). 2i treatment from days 16–20 increased the per-
centage of Nanoghigh cells as expected, but MEK and IKK inhi-
bition also increased this ESC-like population relative to the
DMSO only control and the previous time course experiments.
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Figure 7. Kinase InhibitorModulation of iPSC
Reprogramming End-Stage Trajectories
(A) Tissue culture schematic for kinase inhibitor
modulation of Oct4-GFP primary MEF reprogram-
ming, indicating kinase inhibitor treatment upon
Dox removal from day 16 until day 20. Green arrow
indicates the sample collection time point at day 20.
(B) Nanog 3 Lin28 and CD54 3 MEFSK4 biaxial
plots for day 20 reprogramming MEFs treated with
the indicated small molecule inhibitors from days
16 to 20. 2D gates correspond to the MEFSK4high,
CD54high, Lin28high, and Nanoghigh cell populations
identified in (B).
(C) Number of cells falling into each gate from (B),
as a percentage of the total number of cells in the
sample. Experiment was performed in triplicate,
and error bars indicate SEM.
(D) Kinase inhibitor modulation of selected
signaling molecules in the MEFSK4high, CD54high,
Lin28high, and Nanoghigh cell populations.
See also Figure S7.2i, GSK3-, andMEK-inhibition dramatically reduced the percent-
age of Lin28high cells, but this decrease was not observed when
IKK was inhibited. Along with an increase in Nanoghigh cells, the
percentage of CD54high cells was also increased by 2i, MEK-,
and GSK3-, but not IKK-inhibition.
Heatmap plots of the gated end-stage populations were used
to explore the molecular and cell signaling impact of the kinase
inhibitor treatments (Figure 7D). As expected, MEK-inhibition,
either alone or in the 2i combination, depressed phospho-Erk
levels in all cell types. Decreased phospho-Erk correlated with
decreased Histone H3 Lys9 acetylation in the MEFSK4high,
CD54high, and Lin28high populations, indicating that MEK inhibi-
tion represses transcription via global chromatin compaction.
However, this relationship was not observed in the ESC-like
Nanoghigh population, suggesting that these cells have alterna-
tive cellular signaling pathways responsible for histone acetyla-
tion. PI3K/mTOR inhibition reduced Akt and S6 phosphorylation
as expected and increased compensatory Erk phosphorylation
in a manner similar to previous reports (Paling et al., 2004). TheCell Stem Cell 16, 323–exception to this trend was the Lin28high
population, which saw increased phos-
phorylation of Akt, S6, and Erk, although
these cells experienced Oct4, Ki67, and
H3K9ac loss just as the other cell popula-
tions upon PI3K/mTOR inhibition. The
BEZ-235-induced increase in S6 phos-
phorylation observed in Lin28high cells
may be due to an alternative pathway
through p90 Ribosomal S6 Kinase (RSK)-
dependent phosphorylation.
DISCUSSION
Here, we have applied mass cytometry to
three MEF reprogramming systems,
providing the most comprehensive refer-
ence available for protein expression
measured at the single cell level duringcellular reprogramming. Using a newly developed algorithm for
time-resolved progression analysis on the three time course
data sets, we provide a global continuous map of reprogramming
that includes several well defined stages that appear in all three
reprogramming systems, including an early Oct4highKlf4high stage,
an intermediate partially reprogrammed stage, and a divergent
Lin28high end stage (Figures 3D–3F). The novel combination of
high-dimensional mass cytometry and time-resolved progression
analysis should serve as a useful tool for the study of additional re-
programming systems and for investigation into the dynamic
changes that occur in other complex cell systems such as
directed differentiation and oncogenic transformation.
In the three reprogramming systems examined here, we
observed an initial period of mixed reprogramming factor stoichi-
ometry, followedby the emergence of anOct4highKlf4high cell pop-
ulation. Previous studies have highlighted the importance of Oct4
and Klf4 expression for optimal reprogramming (Carey et al.,
2011; Papapetrou et al., 2009). Here, we propose that the func-
tional consequence of this specific reprogramming stoichiometry337, March 5, 2015 ª2015 Elsevier Inc. 333
is the induction of a partially reprogrammed state that is similar to
previously reported partially reprogrammed cell lines (Meissner
et al., 2007; Theunissen et al., 2011; Wernig et al., 2008). This
Oct4highKlf4high partially reprogrammed state preceded the MET
and showed elevated expression of both mesenchymal and
epithelial markers (Figure 5H). Previous observations of early sto-
chastic and late hierarchic phases of reprogramming (Buganim
et al., 2012), as well as the two transcriptional waves of reprog-
ramming (Polo et al., 2012) may be explained by early mixed re-
programming factor stoichiometries, followed by the emergence
of an OcthighKlf4high population that transitions through a partially
reprogrammed state to the MET and then pluripotency.
Recently, dramatic progress has been made in improving the
speed and efficiency of cellular reprogramming by genetic
depletion of Mbd3, perhaps even rendering the reprogramming
process deterministic (Rais et al., 2013). It is possible that
Mbd3/NuRD complex acts as a ‘‘brake’’ that holds reprogram-
ming MEFs in the SC4-like partially reprogrammed state. Anal-
ysis of published mRNA microarray data revealed that Mbd3fl/
reprogramming MEFs express elevated CD73 and CD104 and
decreased CD54 at the day 4 time point, but return to baseline
levels by day 11, suggesting that this culture system passes
through an accelerated SC4-like partially reprogrammed state
rather than bypassing it completely.
Efforts to identify reprograming conditions though small mole-
cule inhibitors alone have also made great progress recently
(Hou et al., 2013). Small molecule-based reprogramming has
important advantages for translational applications, including
ease of standardization as well as generating iPSCs without ge-
netic modification. Single cell analysis could play an important
role as these protocols are further optimized for mice and adapt-
ed to human reprogramming, because the speed and efficiency
of small molecule reprogramming is much lower than transcrip-
tion factor-based induction of pluripotency. The importance of
rare population analysis is therefore increased in these systems,
and mass cytometry is an attractive option for analysis because
its antibody-based readout allows direct access to post-transla-
tional modifications and cell signaling—the mode of action for
small molecule reprogramming. The methods and data sets
reported here will prove a useful resource for reprogramming
optimization and other mechanistic studies of cellular reprog-
ramming, as well as for the study of additional complex cell pop-
ulations that change dynamically over time.
EXPERIMENTAL PROCEDURES
Viral Preparation
HEK293T cells were transfected with lentiviral vectors containing Oct4, Sox2,
Klf4, and c-Myc under the control of the tetracycline operator and a minimal
CMV promoter, to produce replication-incompetent lentiviral particles with a
VSV-G envelope.
Tissue Culture
MEFswere prepared as described previously (Wernig et al., 2008) and cultured
in MEF medium (DMEM, 10% CCS, b-mercaptoethanol, sodium pyruvate,
non-essential amino acids, Pen/Strep. Cryogenically preserved passage
0 MEFs were thawed and expanded for three passages and then seeded
onto gelatin-coated 10-cm plates at a density of 250,000 cells per plate. For
primary MEF infection, freshly prepared lentiviral supernatant was added to
the culture medium 1 day after seeding. One day after infection, reprogram-
ming factor expression was induced (day 0) by the addition of 2 mg/ml Dox334 Cell Stem Cell 16, 323–337, March 5, 2015 ª2015 Elsevier Inc.(Sigma-Aldrich). MEF culture medium with Dox was refreshed every 2 days
until day 16, at which point the medium was replaced with 123 Medium
(Knockout DMEM, 12% KSR, 3% CCS, beta-mercaptoethanol, Sodium Pyru-
vate, Non-essential Amino Acids, Pen/Strep) supplemented with Leukemia
Inhibitory Factor and refreshed every 2 days. Neomycin selection was per-
formed on the Nanog-Neo secondary MEF reprogramming culture from
days 24 to 30 with 400 mg/ml G418. IdU incorporation was performed as pre-
viously described (Behbehani et al., 2012) at 1 mM for 15 min before dissocia-
tion. For kinase inhibitor treatment, DMSO stocks were added to the medium
at 1:1,000, and the medium was refreshed daily. GSK3 inhibitor CHIR-99021
(Stemgent) was used at 3 mM, MEK inhibitor PD-0325901 (LCLabs) was
used at 1 mM, IKK inhibitor X (Millipore) was used at 10 mM, and PI3K/mTOR
inhibitor BEZ-235 (LCLabs) was used at 1 mM.
Cell Dissociation, Fixation, and Permeabilization
Reprogramming MEF cultures were washed once with 37C HBSS and then
incubated with 103 TrypLE (Life Technologies) for 3 min at 37C. The cells
were then triturated into a single-cell suspension with a 10-ml transfer pipet
and filtered through a 40-mm filter. Filtered cells were fixed at room tempera-
ture with 1.6% paraformaldehyde and then permeabilized with ice-cold meth-
anol, as previously described (Krutzik et al., 2005).
Mass-Tag Cell Barcoding
Cell samples were individually Mass-tag Cell Barcoded (MCB) as previously
described (Bodenmiller et al., 2012; Zunder et al., 2015). Methanol-permeabi-
lized cells were washed once with Cell Staining Medium (CSM, PBS with 0.5%
BSA, 0.02% NaN3) and then once with PBS. Different combinatorial mixtures
of Palladium-containing MCB reagents in DMSO were then added to the
individual samples at 1:100 DMSO with vortexing and then incubated at
room temperature for 30min, followed by three washes with CSM. The individ-
ual samples were then pooled for antibody staining and mass cytometry anal-
ysis. TheseMCBmodifications are discussed in greater detail in Supplemental
Information.
Mass Cytometry Antibodies
Themass cytometry antibodies used in this study are summarized in Table S1,
including antibody clone, vendor, metal isotope, and staining concentration.
All antibodies were conjugated to isotopically pure lanthanide metal using
the MaxPAR antibody conjugation kit (DVS Sciences), according to the man-
ufacturer’s recommended protocol. Labeled antibodies were stored at 4C
in PBS-based Antibody Stabilizer (Candor Bioscience). A single antibody
staining cocktail was prepared for the three reprogramming time courses
and then split into one-third and two-thirds volumes for addition of anti-Sox2
antibody, which needed to be used at a lower concentration of 200 ng/ml on
the Nanog-GFP secondary MEF samples. This was required because
higher-induced Sox2 expression resulted in CyTOF detector saturation at
2000 ng/ml as was used for the Oct4-GFP and Nanog-Neo MEFs. A separate
staining cocktail using the same antibody concentrations was prepared for the
MCB-multiplexed kinase inhibitor-treated samples.
Mass Cytometry Measurement and Data Processing
MCB-multiplexed, antibody-stained cell samples were analyzed on a CyTOF
mass cytometer (DVS Sciences) in several runs at a rate of 500 cells per
second or less. Normalization for detector sensitivity was performed as previ-
ously described (Finck et al., 2013), using normalization beads containing
Lanthanum-139, Praseodymium-141, Terbium-159, Thulium-169, and Lute-
tium-175. After measurement and normalization, the individual FCS files for
each barcoded sample were concatenated, and each barcoded sample was
de-barcoded to the individual samples as previously described (Bodenmiller
et al., 2012). Cell events with zero signal on the Histone H3 acetyl-Lys9 and
Rb phospho-Ser807/11 channels were gated out as non-nucleated cell
fragments.
FLOW-MAP Analysis
Density-dependent downsampling, hierarchical clustering, cluster upsam-
pling, and extraction of parameter medians was performed by the SPADE
package (http://www.cytospade.org) as described in the main text and as pre-
viously described (Linderman et al., 2012; Qiu et al., 2011). Cell clusters and
their attendant median values were used to build FLOW-MAP graphs by
scripts written with the R language and environment for statistical computing
(http://www.R-project.org/) and the igraph package (http://igraph.sf.net)
(E.R.Z., P.F.G., and G.P.N., unpublished data) and are described in the Sup-
plemental Information. Force-directed layout of the FLOW-MAP graphs was
performed using the ForceAtlas2 algorithm (Jacomy et al., 2014) from the Ge-
phi software package (http://www.gephi.org) (Bastian et al., 2009).
Intracellular FACS Sort for RNA Extraction and Microarray Analysis
Isolation of RNA from intracellularly stained, FACS sorted samples is
described in the Supplemental Experimental Procedures. Amplified cDNA
was prepared from the extracted RNA using the Ovation Pico WTA System
V2 (Nugen) according to the manufacturer’s instructions. cDNA samples
were analyzed by Mouse Genome 430 2.0 Microarray (Affymetrix) at the Stan-
ford PAN facility, deposited in NCBI’s Gene Expression Omnibus (Edgar et al.,
2002), and are accessible through GEO Series accession number GSE56764
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=abehwqeihnsrzoh&
acc=GSE56764). Cluster analysis was performed on the microarray data sets
using Cluster (http://rana.lbl.gov/EisenSoftware.htm) and Java Treeview
(http://jtreeview.sourceforge.net/) as previously described (Eisen et al., 1998;
Saldanha, 2004).
Immunofluorescence Imaging
MEFs were seeded onto 6-well plates and subjected to reprogramming condi-
tions via lentiviral infection and doxycycline induction. At the indicated time
points, the cultures were washed once with PBS and then fixed by incubation
with 4% paraformaldehyde in PBS at room temperature for 15 min. After fixa-
tion, the wells were washed three times with PBS and then stored at 4C.
Before antibody staining, the wells were incubated with blocking solution
(5% FBS, 0.1% Triton X-100 in PBS) for 30min at room temperature. The wells
were then incubated with the indicated primary antibodies in blocking solution
for 30 min at room temperature, washed three times with PBS, then incubated
with the indicated fluorophore-conjugated secondary antibodies in blocking
solution for 30 min at room temperature shielded from light and washed
three times with PBS. Before imaging, the wells were incubated with 1 mg/ml
Hoechst 33342 dye in PBS for 30 min at room temperature shielded from
light and thenwashed oncewith PBS. Imageswere acquired using an Axio Ob-
server.A1 microscope, an AxioCam MRC camera, and AxioVision software
4.8.1 (Zeiss).
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